CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.
Jonathan Lapin, PharmD
Advertisement
Articles by Jonathan Lapin, PharmD
This highlighted study looks at using these 2 therapies concurrently for this infection.
Advertisement
Latest Updated Articles
Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA BacteremiaPublished: September 18th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Ethiopia Investigates Marburg Virus Disease Outbreak
2
World AIDS Day 2025: Global Setbacks and New Strategies to Sustain Progress Toward 2030 HIV Targets
3
HIV Drug Resistance Declines in the Modern ART Era
4
Scynexis Collaborates With Hackensack Meridian CDI, Johns Hopkins to Develop Therapeutics for Drug-Resistant Fungal Infections
5
